| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/25/2002 | WO2002033376A2 Polypeptides inhibiting hepatitis c virus internal ribosome entry site (ires), and method for screening said polypeptides |
| 04/25/2002 | WO2002033127A2 Method for assessing recoding in vitro and in vivo |
| 04/25/2002 | WO2002033126A2 Solid support assay systems and methods utilizing non-standard bases |
| 04/25/2002 | WO2002033124A1 KChAP-MODULATOR OF POTASSIUM CHANNELS |
| 04/25/2002 | WO2002033119A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 04/25/2002 | WO2002033114A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2002033113A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2002033112A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2002033102A1 Receptor mediated activation of heterotrimeric g-proteins |
| 04/25/2002 | WO2002033100A2 Regulation of human adenylate cyclase, type iv |
| 04/25/2002 | WO2002033099A2 Human kinases |
| 04/25/2002 | WO2002033095A2 Regulation of human serine-threonine protein kinase |
| 04/25/2002 | WO2002033086A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | WO2002033084A2 Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family |
| 04/25/2002 | WO2002033079A2 Human g-protein coupled receptor and uses thereof |
| 04/25/2002 | WO2002033063A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis |
| 04/25/2002 | WO2002033049A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | WO2002033044A2 Methods of high-throughput screening for internalizing antibodies |
| 04/25/2002 | WO2002032961A2 Novel polypeptides and nucleic acids encoding same |
| 04/25/2002 | WO2002032960A2 Methods of selecting compounds for modulation of bladder function |
| 04/25/2002 | WO2002032958A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 04/25/2002 | WO2002032955A1 Human gene critical to fertility |
| 04/25/2002 | WO2002032953A2 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | WO2002032944A2 Basb208 nucleotide and amino acid sequences from haemophilus influenzae |
| 04/25/2002 | WO2002032941A2 The function of a haptoglobin-haemoglobin receptor and the uses thereof |
| 04/25/2002 | WO2002032937A2 Neuromedin u delta |
| 04/25/2002 | WO2002032936A2 E. histolytica-specific antibodies and clinical uses thereof |
| 04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 04/25/2002 | WO2002032567A1 Method and device for the integrated synthesis and analysis of analytes on a support |
| 04/25/2002 | WO2002032559A1 Paste, which can undergo screen printing, for producing a porous polymer membrane for a biosensor |
| 04/25/2002 | WO2002032458A2 System and methods for optimized drug delivery and progression of diseased and normal cells |
| 04/25/2002 | WO2002032455A2 Vaccine |
| 04/25/2002 | WO2002032448A1 Remedies for obesity and obesity-associated diseases and method of evaluating these remedies |
| 04/25/2002 | WO2002032422A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | WO2002032419A2 Methods for modulating bladder function |
| 04/25/2002 | WO2002032404A2 Nanoparticles |
| 04/25/2002 | WO2002032303A2 Glucose measurement utilizing non-invasive assessment methods |
| 04/25/2002 | WO2002032288A2 Cd38 modulated chemotaxis |
| 04/25/2002 | WO2002032286A2 Protein-protein interactions in neurodegenerative diseases |
| 04/25/2002 | WO2002010751A3 Transfer microdissection |
| 04/25/2002 | WO2002009583A3 Apparatus and methods for comprehensive blood analysis, including work of, and contractility of, heart and therapeutic applications and compositions thereof |
| 04/25/2002 | WO2001096873A3 Method for identifying apoptosis-modified proteins |
| 04/25/2002 | WO2001094920A3 3d array of integrated cells for the sampling and detection of air bound chemical and biological species |
| 04/25/2002 | WO2001088136A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | WO2001073429A3 Detection of redox-active molecules in solution |
| 04/25/2002 | WO2001072831A3 Immunoregulator |
| 04/25/2002 | WO2001072782A3 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 04/25/2002 | WO2001068907A3 Stable expression of polymorphous forms of human cytochrome P450 2D6 |
| 04/25/2002 | WO2001064939A3 Process for obtaining inhibitors/activators of an enzyme |
| 04/25/2002 | WO2001062306A3 Method and device for controlling the capacity between two electrodes in a gas |
| 04/25/2002 | WO2001061357A3 Method and apparatus for detection of microscopic pathogens |
| 04/25/2002 | WO2001061041A3 Multiple-site reaction device and method |
| 04/25/2002 | WO2001061010A3 GTPASE activating proteins |
| 04/25/2002 | WO2001060975A3 Gene disruption methodologies in fungi for drug target discovery |
| 04/25/2002 | WO2001060174A3 Weight loss induced by reduction in neuropeptide y level |
| 04/25/2002 | WO2001059453A3 Biosensor compositions and methods of use |
| 04/25/2002 | WO2001057241A3 Cast analyte diffusion-limiting membranes using photopolymerizable hydrophylic monomers |
| 04/25/2002 | WO2001057240A3 Interaction of nmda receptor with protein tyrosine phosphatase |
| 04/25/2002 | WO2001053814A3 Gas sensor with a gel layer for determination of moisture content |
| 04/25/2002 | WO2001052904A3 Pharmaceutical compositions and methods of treatment based on VEGF antisense oligonucleotides |
| 04/25/2002 | WO2001047533A3 INHIBITION OF GSK-3$g(b) |
| 04/25/2002 | WO2001044500A3 Method and device for fluid quality measurement |
| 04/25/2002 | WO2001040517A3 Evaluating and predicting clinical outcomes by gene expression analysis |
| 04/25/2002 | WO2001038580A3 Nucleic acid probe arrays |
| 04/25/2002 | WO2001014846A3 Methods and assay kits for detecting a pro-ms immune response via assay of B cells |
| 04/25/2002 | US20020049987 Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof |
| 04/25/2002 | US20020049726 Systems and methods for storing, retrieving, and manipulating data in medical processing devices |
| 04/25/2002 | US20020049712 Method for detection of prostate specific membrane antigen in serum |
| 04/25/2002 | US20020049543 Method for displaying gene experiment data |
| 04/25/2002 | US20020049390 Collection well for body fluid tester |
| 04/25/2002 | US20020049374 Method and apparatus for signal transmission and detection using a contact device |
| 04/25/2002 | US20020049307 Selective labeling and isolation of phosphopeptides and applications to proteome analysis |
| 04/25/2002 | US20020049302 Purification of preferential lymphocytes; incubate modulator with cells, detect lymphocytes expressing detectable markers |
| 04/25/2002 | US20020049177 Detecting an aberrant level or bioactivity of or screening for a Wnt pathway component or a frizzled related protein gene product |
| 04/25/2002 | US20020049176 Administration of an agent that promotes mitochondrial biogenesis by induction of a PGC gene and/or a nuclear regulatory factor gene; Screening assays for agents that regulate such genes |
| 04/25/2002 | US20020049161 Especially Fe(III) saccharate and gluconate; treatment of hemodialysis patients. |
| 04/25/2002 | US20020049160 Identifying an agent that increases an N-Methyl-D-Aspartate (NMDA) receptor mediated response in a neuron to an agonist |
| 04/25/2002 | US20020049152 Generally in the same orientation, can be full-length and biologically active, and can be readily screened for a desired activity. |
| 04/25/2002 | US20020049151 Therapeutic approaches to diseases by suppression of the NURR subfamily of nuclear transcription factors |
| 04/25/2002 | US20020048823 Methods and universal monoclonal antibody array |
| 04/25/2002 | US20020048822 Marking of products with electroactive compounds |
| 04/25/2002 | US20020048821 Sample preparing arrangement and a method relating to such an arrangement |
| 04/25/2002 | US20020048818 Chemical monitoring method and apparatus, and incinerator |
| 04/25/2002 | US20020048811 Polypeptide for use in in situ detection and drug screening |
| 04/25/2002 | US20020048794 Polypeptides for use in the diagnosis and treatment of skin disorders, cancer, vision and demyelination defects, inflammation, glomerculonephritis, Kaposi's sarcoma, angiogenesis, sarcoidosis, osteoarthritis and aneurysm |
| 04/25/2002 | US20020048790 Nucleotide sequences coding binding protein for use in the prevention of infections; bactericides |
| 04/25/2002 | US20020048787 Peptides; for use in development of human therapeutics and diagnostic testing |
| 04/25/2002 | US20020048786 Nucleotide sequences for use in the treatment of infections, arthritis, karposi's sarcoma, allergies, asthma, nervous system and autoimmune diseases |
| 04/25/2002 | US20020048783 Immunoglobulin for use in the detection of preferential proteins in bodily fuids of mammals |
| 04/25/2002 | US20020048782 Pyk2 related products and methods |
| 04/25/2002 | US20020048779 Method of assaying pyrrole-containing biological compounds |
| 04/25/2002 | US20020048778 Particle for use in detection of protein binding positions; antitumor agents |
| 04/25/2002 | US20020048777 Nucleotide sequences for use in therapy, monitoring and screning preferential tumors |
| 04/25/2002 | US20020048776 Detecting binding peptides; determine structure of preferential polypeptides, analyze surface of binding position, detect binding positions, evaluate binding of peptides to binding position |
| 04/25/2002 | US20020048775 Diagnostic methods for asthma |
| 04/25/2002 | US20020048770 Electrospraying solutions of substances for mass fabrication of chips and libraries |
| 04/25/2002 | US20020048769 Protein-protein interactions in neurodegenerative disorders |
| 04/25/2002 | US20020048765 Apparatus for use as diagnostic tool in drug screening, environmental monitoring and forensic analysis |
| 04/25/2002 | US20020048764 Human PEM as a target for birth contol and treatment of Alzheimer's disease |
| 04/25/2002 | US20020048758 Carrier for gene detection and its use for detecting validity of interferon therapy |